We’re excited to announce the new Medaxis website is live! 🚀

Built with healthcare professionals, DME suppliers, and patients in mind, our redesigned site offers a streamlined, user-friendly experience — and proudly brings our bold new Medaxis brand to life.

We invite you to explore the new site and discover how Medaxis embodies healing made simple.

🔗 www.medaxis.com

Medaxis, a leader in advanced wound care technologies, is pleased to announce the promotion of Blane Sanders to Chief Marketing and Product Officer. In this expanded executive role, Sanders will lead global marketing, product innovation, and portfolio strategy as Medaxis accelerates its growth and impact in the wound care market.

With more than 20 years of medical device leadership experience, Sanders has held key roles at KCI/3M and Medline, where he helped shape the commercialization of negative pressure wound therapy (NPWT) and other advanced wound healing technologies. Since joining Medaxis, Sanders has played a critical role in advancing product development and bringing new therapies to market.

“Blane’s deep understanding of the wound care landscape, combined with his strategic vision and relentless focus on execution, makes him the ideal leader to guide our marketing and product strategy,” said Jeffrey Castillo, Chief Executive Officer at Medaxis. “This promotion reflects both his contributions and our commitment to advancing innovation that truly matters to patients and clinicians alike.”

In his new capacity, Sanders will focus on accelerating the Medaxis product pipeline, deepening clinician partnerships, and expanding the company’s reach in key markets across the globe.

“It’s a privilege to step into this role during such a transformative period for Medaxis,” said Sanders. “We have a mission-driven team, an expanding portfolio, and a clear vision to redefine what’s possible in wound therapy. I’m excited to help lead the next chapter of growth.”

Medaxis is pleased to announce the promotion of Dave Johnson to Chief Operating Officer. In this new role, Dave will oversee company-wide operations, ensuring strategic alignment and operational excellence as Medaxis continues to expand its global presence.

Dave Johnson brings over two decades of experience in healthcare operations, supply chain, and organizational leadership. Since joining Medaxis, he has been instrumental in streamlining internal processes, enhancing cross-functional collaboration, and driving sustainable growth across the company’s wound therapy portfolio.

“Dave’s leadership has been a cornerstone of our operational success,” said Jeffrey Castillo, Chief Executive Officer of Medaxis. “His ability to lead with clarity, drive efficiency, and inspire teams makes him the ideal choice to step into the COO role as we enter our next phase of growth.”

As COO, Dave will lead the company’s operational strategy, supply chain management, and business process optimization, with a focus on delivering high-quality, cost-effective solutions to healthcare providers and patients worldwide.

“I’m honored to take on this new role and continue contributing to Medaxis’ commitment to wound therapy solutions,” said Dave Johnson. “We have a remarkable team and a powerful vision, and I look forward to helping scale our impact in the years ahead.”